Bill > HR4304

This bill, known as the Increase Support for Life-saving Endocrine Transplantation Act or the ISLET Act, aims to regulate human cadaveric islets (insulin-producing cells from the pancreas) for transplantation as organs. Specifically, the bill amends the Public Health Service Act to include human cadaveric islets as a type of organ that is regulated under the existing framework for organ transplantation. The bill also clarifies that human cadaveric islets are not considered "drugs," "biological products," or "human cells, tissues, or cellular or tissue-based products (HCT/Ps)" under other relevant laws and regulations. Additionally, the bill requires the Secretary of Health and Human Services to update relevant regulations within one year of the bill's enactment and to provide a report to Congress on the progress made in updating these regulations within six months.